drugset / Trial / NCT00934180
Ondansetron HCl Orally Disintegrating Tablets Under Fasting Conditions
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study was to compare the relative bioavailability of the test formulation of Ondansetron HCl with the already marketed reference formulation Zofran ODT under fasting conditions in healthy, non-smoking adult subjects.
Timeline
- Start
- 2002-12
- Primary completion
- 2002-12
- Completion
- 2002-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ondansetron | Other / unclassified | 8 mg | Oral |
Indications
No indication recorded.